ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000233030.2	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.019377095	Resistant
ENSG00000233030.2	ABT-263 (navitoclax)	Breast invasive carcinoma	0.018899258	Sensitive